about
Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transitionNear-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labelingMicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functionsProteome-wide profiling of the MCF10AT breast cancer progression modelM402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasisActivator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.Molecular changes in bone marrow, tumor and serum after conductive ablation of murine 4T1 breast carcinoma.Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.Rapid disorganization of mechanically interacting systems of mammary acini.Smad4-expression is decreased in breast cancer tissues: a retrospective study.Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.Beyond Warburg effect--dual metabolic nature of cancer cells.Encapsulation of poorly soluble drugs in polymer-drug conjugates: effect of dual-drug nanoformulations on cancer therapy.Stem cells in the human breastOral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype.ATM suppresses SATB1-induced malignant progression in breast epithelial cellsAPC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphologyActivation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model.Delivery-corrected imaging of fluorescently-labeled glucose reveals distinct metabolic phenotypes in murine breast cancerMicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions.Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles.Non-invasive, simultaneous quantification of vascular oxygenation and glucose uptake in tissue.Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.Complex alternative splicing of the smarca2 gene suggests the importance of smarca2-B variantsThe type III TGF-beta receptor suppresses breast cancer progressionTarget modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targetingHydrodynamic cell delivery for simultaneous establishment of tumor growth in mouse lung, liver and kidneyDietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c miceDifferential Contribution of Acute and Chronic Inflammation to the Development of Murine Mammary 4T1 TumorsStromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently.Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4.Intravital Förster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli.Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growthInduction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer CellsIdentification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
P2860
Q27334832-8ED8F9DE-4117-4D2C-8BC6-22FAEC92CACFQ27340657-362AC264-E2C4-4E55-9F44-6091948A34F5Q28297593-8229F818-A9DC-4F12-B634-303DFC7C60B2Q28474333-E198C160-3E77-4E1E-A503-1A6FA784C5F0Q28743550-73393B9D-B603-4A90-9F9A-44CBB43D4C2CQ30427356-C3D57142-39B3-4232-B2FD-2BEB9498EBAFQ30444038-287A041E-FAF5-442C-A6E9-AF8DCA4746F5Q30554443-6F7738A8-04CA-4391-930C-C4CC9878E6D5Q30565921-D23D2402-E199-4CBC-A336-F450B82372E6Q33232550-8A66649D-11D4-4A30-8F7A-E45BBECADB4DQ33510688-A11C86A6-09B5-4467-8075-A082F2FFB17CQ33600827-A74A1994-44EF-4AC0-AED5-CFB7EC979405Q33686380-27B75EBC-1397-40A3-8808-CFD5671AF10AQ33800311-68FF4F68-8179-4848-A55C-D326182CA218Q34103876-3F8231E0-6C05-456E-B6D3-EB000DA40E0EQ34154917-A6398545-E101-4EEB-9344-A607C6560007Q34440549-08AC2BFA-CE84-4AC5-8D30-AE1D240A0D49Q34517226-1AEF7A1C-7BCB-46FA-AF0C-81B10DB1B5E4Q34542769-1DE61AF3-F430-4ABA-AFF6-47DFB3A1A878Q34609774-5601D109-8799-479A-8F94-3719F2FE801DQ34634293-60462464-19AC-44F4-BF82-5B066838A922Q34646864-787E7AAA-FA32-4912-9EDE-D9D619CE145AQ34744489-0B73F957-975E-493A-A3DA-75FEBDB6C692Q34991074-57C9F821-3E6C-480A-A1A3-0163714B8917Q35021021-10021E8D-67D5-4D17-BA22-5FDD6CD929EDQ35023993-F2024BC4-E1FD-4105-A0C3-0A48A8122AB0Q35031920-EA391642-591C-407C-8A66-23045819C7D4Q35034709-59260942-DA9A-41D3-880F-7CF7D3EC7A7EQ35142978-82942DBE-F748-4893-B523-6CA96F15BE69Q35191593-23425E51-6593-4B76-A564-9E6E34BD65A7Q35552376-4F8094B0-08DC-43F8-A9F9-BBB622A5F866Q35556784-9C189DAE-F01C-41EE-9D56-896600E4E4D9Q35608714-BDD55FDA-C943-435C-BA02-DF2E57ADA19AQ35687144-4CBDABE5-6C65-4663-8FAF-3DFE1636F827Q35962304-72AAC88E-B839-43B0-B7E8-F77965C0A3C6Q36188228-5A889B09-8EA2-4330-8F78-96B1CD65B4EDQ36222369-6F9D4F9A-AC96-4196-867E-0FDD8A97EDF6Q36322686-B92D8BE8-0391-4EE5-A749-6B4006E59651Q36480181-1F3754B8-D852-4AFA-9A68-E5DFCDE85850Q36489338-1D53804D-60F6-4E6E-BAAF-7609D4DA2D26
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Nontransgenic models of breast cancer
@ast
Nontransgenic models of breast cancer
@en
Nontransgenic models of breast cancer
@nl
type
label
Nontransgenic models of breast cancer
@ast
Nontransgenic models of breast cancer
@en
Nontransgenic models of breast cancer
@nl
prefLabel
Nontransgenic models of breast cancer
@ast
Nontransgenic models of breast cancer
@en
Nontransgenic models of breast cancer
@nl
P2093
P2860
P3181
P356
P1476
Nontransgenic models of breast cancer
@en
P2093
F R Miller
G H Heppner
P M Shekhar
P2860
P2888
P3181
P356
10.1186/BCR77
P407
P577
2000-08-04T00:00:00Z
P5875
P6179
1043244352